CRISM Therapeutics Corporation (AIM:CRTX)
London
· Delayed Price · Currency is GBP · Price in GBX 22.10
-1.40 (-5.96%)
Jun 17, 2025, 2:46 PM GMT+1
CRISM Therapeutics Market Cap
CRISM Therapeutics has a market cap or net worth of 7.68 million as of June 17, 2025. Its market cap has increased by 740.13% in one year.
Market Cap
7.68M
Enterprise Value
6.40M
Revenue
25.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
22.10
Market Cap Chart
Since March 15, 2006, CRISM Therapeutics's market cap has decreased from 28.23M to 7.68M, a decrease of -72.80%. That is a compound annual growth rate of -6.53%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 170.36B |
| GSK plc | 61.23B |
| Haleon | 35.62B |
| Smith & Nephew | 9.57B |
| ConvaTec Group | 5.88B |
| Hikma Pharmaceuticals | 4.69B |
| HUTCHMED (China) | 2.15B |
| Genus | 1.30B |